These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [On oral treatment with heparin and heparinoids]. HEYMANN W Bibl Haematol; 1963; 15():132-9. PubMed ID: 13954327 [No Abstract] [Full Text] [Related]
4. [CONCERNING THE TREATMENT OF XANTHOMATOSIS]. DREWS J Folia Clin Int (Barc); 1963 Sep; 13():416-20. PubMed ID: 14092669 [No Abstract] [Full Text] [Related]
5. [ON THE EFFECTIVENESS OF ANTIATHEROSCLEROTIC DRUGS]. SCHOEN H; ZELLER W; DITTERICH S Med Klin; 1964 Jun; 59():939-43. PubMed ID: 14234234 [No Abstract] [Full Text] [Related]
6. [THE SIGNIFICANCE OF INSUFFICIENT CLEARANCE IN ATHEROGENESIS]. SCHOEN H Munch Med Wochenschr; 1963 Dec; 105():2473-8. PubMed ID: 14133657 [No Abstract] [Full Text] [Related]
7. [ACTION OF DUODENAL HEPARINOID ON GLUCIDE METABOLISM]. BARBEITOARANDA A; PRESS L; GIORDANO J; LOPEZGIL AL; CAMPAGNOLI M Dia Med; 1963 Sep; 35():1491-3. PubMed ID: 14089621 [No Abstract] [Full Text] [Related]
8. [USE OF A SYNTHETIC HEPARINOID IN LIPID METABOLISM DISORDERS. PRELIMINARY STUDY]. RABY C; SAINT-BLANCARD J; PAGE G; BIED B; VIGNE J; OUGIER J Sem Ther; 1963 Dec; 39():658-64. PubMed ID: 14116089 [No Abstract] [Full Text] [Related]
9. [Effect exercised by a heparinoid on hyperlipemia induced in the rabbit by a surface-active agent]. BINET L; MARQUIS M; QUIVY D C R Hebd Seances Acad Sci; 1959 Dec; 249():2693-7. PubMed ID: 13800760 [No Abstract] [Full Text] [Related]
10. On the effect of alimentary lipemia and a natural heparinoid on the fibrinolytic system of man. KONTTINEN Y Scand J Clin Lab Invest; 1962; 14():87-99. PubMed ID: 14458289 [No Abstract] [Full Text] [Related]
11. [Hyperlipemia: clinico-therapeutic experience with a heparinoid]. De Martino G; D'Aniello L; De Simone E; Belli MG; Buonfantino M Clin Ter; 1978 Sep; 86(6):583-95. PubMed ID: 83925 [No Abstract] [Full Text] [Related]
12. [ON CHOLESTEROL MOBILIZATION IN THE TREATMENT OF XANTHOMA AND ATHEROSCLEROSIS]. STUETTGEN G; LEUTIGER H Arzneimittelforschung; 1963 Dec; 13():1092-7. PubMed ID: 14208684 [No Abstract] [Full Text] [Related]
13. [Experimental analysis of the interactions between heparin and a duodenal heparinoid]. Marmo E; Lampa E; Vacca C; Rossi F; Spadaro R; Sannino A Arch Sci Med (Torino); 1975; 132(3):83-115. PubMed ID: 56927 [TBL] [Abstract][Full Text] [Related]
14. [Effect of heparinoids on the blood sugar level and blood lipids in diabetes mellitus]. Markoski S Vutr Boles; 1977; 16(6):52-8. PubMed ID: 74910 [TBL] [Abstract][Full Text] [Related]
15. [On clinical trials with Heparinoid Sp 54 in lipemia]. HIGASHINO S; MIYAMOTO T; SAWA C; ISHIMARU Y; KAWASHIMA Y; SUDA M Chiryo; 1963 Jul; 45():1279-85. PubMed ID: 13954395 [No Abstract] [Full Text] [Related]
16. [CLEARING ACTION OF HEPARIN AND HEPARINOID SUBSTANCES IN THERAPY OF ARTERIOSCLEROSIS]. MEONI G Clin Ter; 1965 Mar; 32():445-60. PubMed ID: 14333171 [No Abstract] [Full Text] [Related]
17. [ON THE CLINICAL ASPECTS AND THERAPY OF HYPERLIPEMIA]. FORSTER G; MUELLER J; ALSLEBEN U; BERNHEIM C Schweiz Med Wochenschr; 1964 Jun; 94():833-41. PubMed ID: 14250316 [No Abstract] [Full Text] [Related]
18. [The effect of heparin and heparinoids on aldosterone production]. GLAZ E; SUGAR K Orv Hetil; 1963 Jul; 104():1360-3. PubMed ID: 13948412 [No Abstract] [Full Text] [Related]
19. [THE BIOLOGICAL SYNDROME OF ARTERIOSCLEROSIS AND ITS CLINICAL VALUE]. DE BETTENCOURT JM J Soc Cienc Med Lisb; 1963 Mar; 127():155-79. PubMed ID: 14113565 [No Abstract] [Full Text] [Related]